November 18, 2026
Health news, explained with evidence
LIVE

Historical Genetic Test Results for Inherited Heart Condition Shift Under Modern Criteria

🧠 AI Analysis 2 min read 👁 3

A long-term study of patients with hypertrophic cardiomyopathy shows that nearly 13% of identified genetic variants changed classification when reassessed using updated evaluation standards.

🧠AI Analysis

Key points

  • Researchers reassessed 1,355 genetic variants in 2,154 HCM patients evaluated at Barts Heart Centre between 2003 and 2025.
  • 12.8% of genetic variants changed classification under current guidelines, altering the diagnosis for 86 patients (4%).
  • Loss-of-function variants remained highly stable, while missense variants in several minor genes were more prone to clinical downgrading.

A re-evaluation of historical genetic testing data for hypertrophic cardiomyopathy (HCM) has revealed that 12.8% of identified genetic variants changed their scientific classification when reviewed under modern diagnostic frameworks. Conducted by Bakalakos and colleagues using records from the Barts Heart Centre in London, UK, the study analyzed 1,355 genetic variants across 2,154 HCM probands initially tested between 2003 and 2025.

Applying contemporary guidelines from the American College of Medical Genetics and Genomics (ACMG) and ClinGen gene-disease validity assessments, researchers observed that 7.5% of variants shifted across clinically critical categories. As a result, 86 patients—representing 4% of the cohort—had their genetic diagnosis altered. Among these individuals, 47 lost a previously assigned pathogenic or likely pathogenic variant, while 39 gained one. Stability varied significantly by mutation type: loss-of-function variants in genes such as MYBPC3 and ALPK3 remained almost entirely unchanged, whereas missense variants in minor HCM genes including TNNI3, TPM1, ACTC1, MYL2, and MYL3 were frequently downgraded to variants of uncertain significance. In contrast, variants in TNNT2 saw a 23% net increase in pathogenic status.

Hypertrophic cardiomyopathy affects approximately 1 in 500 individuals and represents one of the most thoroughly researched monogenic conditions, dating back to the discovery of the MYH7:p.Arg403Gln variant in 1990. While genetic testing remains central to predictive family screening, these findings demonstrate that interpretation standards evolve even as underlying DNA remains static. Because the study reflects data from a single specialized inherited cardiac condition center, ongoing updates across broader population datasets remain essential.

What to know

Patients who underwent genetic testing for inherited heart conditions in earlier years may periodically require updated interpretations as genomic evidence grows. Individuals should consult a medical doctor or genetic counselor before making personal health decisions based on historical test results.

Source Nature Health Sciences — nature.com/articles/s41431-026-02269-6 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.